睡眠问题的异质性和抑郁症成年人的自杀风险:一个横截面研究
Honglan Shi1, Jing Sun2, Yanrong Wang1
1Mental Health Center, General Hospital of Ningxia Medical University, No.804 South Shengli Street, Yinchuan, 750004 Ningxia China.
Sleep and biological rhythms
|January 13, 2025
概括
抑郁成年人的睡眠质量差和白天功能障碍显著增加了自杀风险. 识别特定的睡眠模式可以帮助针对性干预,并减少这一脆弱人群的自杀率.
科学领域:
- 精神病学是一个精神病学.
- 睡眠医学 睡眠医学
- 流行病学 流行病学
背景情况:
- 抑郁症是自杀的主要危险因素.
- 睡眠障碍在患有抑郁症的患者中很常见.
- 抑郁症成年人的各种睡眠质量参数与自杀风险之间的具体关系需要进一步阐明.
研究的目的:
- 调查不同睡眠质量水平与被诊断患有抑郁症的成年人中自杀风险之间的关联.
- 为了确定可能预测更高自杀风险的特定睡眠模式.
- 为减少抑郁症患者自杀率的治疗策略提供信息.
主要方法:
- 一项涉及301名患有抑郁症的成年人从中国宁夏一家医院招募的研究.
- 使用匹兹堡睡眠质量指数 (PSQI) 评估睡眠质量,使用自我评价抑郁症量表 (SDS) 评估抑郁症严重程度.
- 隐性类分析 (LCA) 来分类睡眠模式和多变量逻辑回归来分析睡眠质量与自杀风险之间的关系.
主要成果:
- 确定了四个不同的睡眠质量类别:"全球睡眠障碍"",睡眠质量差"",睡眠时间短"",睡眠质量好".
- 总体睡眠质量差,白天功能障碍严重的成年人,与睡眠质量好的人相比,自杀的风险更高.
- 特定的睡眠变量表明了潜在的自杀风险预测价值.
结论:
- 睡眠质量差和白天功能障碍是抑郁成年人自杀风险升高的重要指标.
- 了解抑郁症中睡眠模式的细微差别可以指导开发更有效的自杀预防策略.
- 这些发现为改善成人抑郁症治疗干预措施的基础,并最终降低自杀率.
相关概念视频
Insufficient Sleep and Sleep Deprivation
131
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Sleep deprivation is a more severe form of sleep loss...
131
Depressive Disorders: Etiology
40
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
40
Depression: Overview
212
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
212
Depressive Disorders: MDD and Dysthymia
51
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
51
Sedatives and Hypnotics Drugs: Miscellaneous Agents
145
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
145
Insomnia
79
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
79


